Sms Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is PANTOPRAZOLE SODIUM USP, with a corresponding US DMF Number 29129.
Remarkably, this DMF maintains an Active status since its submission on March 04, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 21, 2016, and payment made on September 09, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II